Product Code: ETC8284006 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Narcolepsy Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Narcolepsy Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Narcolepsy Market - Industry Life Cycle |
3.4 Mexico Narcolepsy Market - Porter's Five Forces |
3.5 Mexico Narcolepsy Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Mexico Narcolepsy Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
4 Mexico Narcolepsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about narcolepsy and its symptoms in Mexico |
4.2.2 Rising prevalence of narcolepsy among the Mexican population |
4.2.3 Technological advancements in the diagnosis and treatment of narcolepsy in Mexico |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for narcolepsy treatment in Mexico |
4.3.2 High cost associated with narcolepsy medications and therapies in the Mexican market |
5 Mexico Narcolepsy Market Trends |
6 Mexico Narcolepsy Market, By Types |
6.1 Mexico Narcolepsy Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Mexico Narcolepsy Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Mexico Narcolepsy Market Revenues & Volume, By Daytime Extreme Sleepiness, 2021- 2031F |
6.1.4 Mexico Narcolepsy Market Revenues & Volume, By Cataplexia, 2021- 2031F |
6.1.5 Mexico Narcolepsy Market Revenues & Volume, By Other Disease Type, 2021- 2031F |
6.2 Mexico Narcolepsy Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Mexico Narcolepsy Market Revenues & Volume, By Central Nervous System Stimulants, 2021- 2031F |
6.2.3 Mexico Narcolepsy Market Revenues & Volume, By Tricyclic Antidepressants, 2021- 2031F |
6.2.4 Mexico Narcolepsy Market Revenues & Volume, By Sodium Oxybate, 2021- 2031F |
6.2.5 Mexico Narcolepsy Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitor, 2021- 2031F |
6.2.6 Mexico Narcolepsy Market Revenues & Volume, By Other Therapeutic Type, 2021- 2031F |
7 Mexico Narcolepsy Market Import-Export Trade Statistics |
7.1 Mexico Narcolepsy Market Export to Major Countries |
7.2 Mexico Narcolepsy Market Imports from Major Countries |
8 Mexico Narcolepsy Market Key Performance Indicators |
8.1 Average time taken for narcolepsy diagnosis in Mexico |
8.2 Number of healthcare professionals trained in narcolepsy diagnosis and treatment |
8.3 Patient adherence rate to narcolepsy treatment plans in Mexico |
9 Mexico Narcolepsy Market - Opportunity Assessment |
9.1 Mexico Narcolepsy Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Mexico Narcolepsy Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
10 Mexico Narcolepsy Market - Competitive Landscape |
10.1 Mexico Narcolepsy Market Revenue Share, By Companies, 2024 |
10.2 Mexico Narcolepsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |